⌘K

Login Start Free

Home/Filings/5/0001469709-22-000016

5//SEC Filing

Murray Martin 5

Accession 0001469709-22-000016

CIK 0001085596other

View on SEC.gov Company Profile

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 1:25 PM ET

Size

7.3 KB

Accession

0001469709-22-000016

Insider Transaction Report

Form 5

Period: 2021-12-31

AngioGenex, Inc.AGGX

DirectorSecretary, Treasurer, CFO

Transactions

Award
Stock Option
2019-01-15$0.35/sh+75,000$26,250→ 75,000 total
Exercise: $0.35From: 2019-01-15Exp: 2024-01-15→ Common Stock (75,000 underlying)
Award
Stock Option
2021-09-02$0.13/sh+50,000$6,500→ 125,000 total
Exercise: $0.13From: 2021-09-02Exp: 2026-09-02→ Common Stock (50,000 underlying)

Documents

1 file

5
ownership.xmlPrimary

Issuer

AngioGenex, Inc.

CIK 0001085596

Entity typeother

Related Parties

1

filerCIK 0001360353

Filing Metadata

Form type: 5
Filed: Feb 16, 7:00 PM ET
Accepted: Feb 17, 1:25 PM ET
Size: 7.3 KB

View on SEC.gov